PineBridge Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-17,029
| Closed | -$2.56M | – | 598 |
|
2025
Q1 | $2.56M | Sell |
17,029
-95,596
| -85% | -$14.4M | 0.02% | 397 |
|
2024
Q4 | $20.8M | Sell |
112,625
-23,584
| -17% | -$4.35M | 0.16% | 134 |
|
2024
Q3 | $26.8M | Buy |
136,209
+7,823
| +6% | +$1.54M | 0.2% | 118 |
|
2024
Q2 | $26.5M | Buy |
128,386
+4,497
| +4% | +$929K | 0.21% | 109 |
|
2024
Q1 | $33.6M | Buy |
123,889
+23,508
| +23% | +$6.37M | 0.27% | 82 |
|
2023
Q4 | $23.7M | Buy |
100,381
+18,849
| +23% | +$4.46M | 0.22% | 119 |
|
2023
Q3 | $16M | Buy |
81,532
+7,278
| +10% | +$1.43M | 0.18% | 134 |
|
2023
Q2 | $15.6M | Sell |
74,254
-2,442
| -3% | -$513K | 0.17% | 136 |
|
2023
Q1 | $15.5M | Buy |
76,696
+6,676
| +10% | +$1.35M | 0.17% | 147 |
|
2022
Q4 | $15.3M | Buy |
70,020
+13,958
| +25% | +$3.04M | 0.18% | 150 |
|
2022
Q3 | $11M | Buy |
56,062
+3,286
| +6% | +$647K | 0.14% | 173 |
|
2022
Q2 | $11.3M | Buy |
52,776
+1,694
| +3% | +$362K | 0.14% | 173 |
|
2022
Q1 | $14.5M | Buy |
51,082
+24,267
| +90% | +$6.89M | 0.16% | 156 |
|
2021
Q4 | $10.1M | Sell |
26,815
-3,428
| -11% | -$1.29M | 0.1% | 202 |
|
2021
Q3 | $12.5M | Sell |
30,243
-21,169
| -41% | -$8.74M | 0.15% | 156 |
|
2021
Q2 | $19M | Buy |
51,412
+14,700
| +40% | +$5.44M | 0.22% | 114 |
|
2021
Q1 | $10.6M | Hold |
36,712
| – | – | 0.14% | 194 |
|
2020
Q4 | $9.17M | Sell |
36,712
-4,986
| -12% | -$1.25M | 0.14% | 179 |
|
2020
Q3 | $9.44M | Buy |
41,698
+6,914
| +20% | +$1.57M | 0.16% | 149 |
|
2020
Q2 | $6.07M | Buy |
+34,784
| New | +$6.07M | 0.12% | 198 |
|
2014
Q2 | – | Sell |
-3,249
| Closed | -$196K | – | 1068 |
|
2014
Q1 | $196K | Sell |
3,249
-1,011
| -24% | -$61K | 0.01% | 765 |
|
2013
Q4 | $226K | Sell |
4,260
-1,975
| -32% | -$105K | 0.01% | 744 |
|
2013
Q3 | $288K | Sell |
6,235
-5,233
| -46% | -$242K | 0.01% | 424 |
|
2013
Q2 | $471K | Buy |
+11,468
| New | +$471K | 0.01% | 371 |
|